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a  b  s  t  r  a  c  t
Catalytically  inactive  phospholipase  A2 (PLA2) homologues  play  key  roles  in  the  pathogenesis  induced
by  snake  envenomation,  causing  extensive  tissue  damage  via  a mechanism  still  unknown.  Although,  the
amino acid  residues  directly  involved  in catalysis  are  conserved,  the  substitution  of  Asp49  by  Arg/Lys/Gln
or  Ser  prevents  the  binding  of the  essential  calcium  ion  and  hence  these  proteins  are  incapable  of  hydrolyz-
ing  phospholipids.  In  this  work,  the  crystal  structure  of a Lys49-PLA2 homologue  from  Bothrops  brazili
(MTX-II)  was  solved  in two  conformational  states:  (a) native,  with  Lys49  singly  coordinated  by  the  back-
bone oxygen  atom  of  Val31  and  (b)  complexed  with  tetraethylene  glycol  (TTEG).  Interestingly,  the  TTEG
molecule  was  observed  in  two  different  coordination  cages  depending  on the  orientation  of  the nominal
calcium-binding  loop  and  of the  residue  Lys49.  These  structural  observations  indicate  a  direct  role  for
the residue  Lys49  in  the  functioning  of  a catalytically  inactive  PLA2 homologue  suggesting  a contributionligomerization of  the active  site-like  region  in the  expression  of pharmacological  effects  such  as  myotoxicity  and  edema
formation.  Despite  the  several  crystal  structures  of Lys49-PLA2 homologues  already  determined,  their
biological  assembly  remains  controversial  with  two  possible  conformations.  The  extended  dimer  with
the hydrophobic  channel  exposed  to the  solvent  and the  compact  dimer  in  which  the active site-like
region  is occluded  by the dimeric  interface.  In the  MTX-II  crystal  packing  analysis  was found  only  the
ible  sextended  dimer  as a  poss
. Introduction
Phospholipases A2 (PLA2s) represent the major venom compo-
ent of snakes belonging to genus Bothrops and exhibit a broad
ange of biological effects including neurotoxicity, myotoxicity,
ardiotoxicity, hemolysis, anticoagulant and antiplatelet activities
1–4]. Snake venom PLA2s are classiﬁed into two  main subgroups
ased on the presence of an aspartic acid residue at position 49 in
he catalytically active Asp49-PLA2 enzymes, or a lysine in homo-
ogues (Lys49-PLA2s; reviewed in [5–7]) that are considered to
e catalytically inactive due to their inability to hydrolyze natural
hospholipids [8]. Other substitutions such as arginine at position
9 have been observed in the catalytically inactive PLA2 homologue
rom Zhaoermia mangshanensis venom [9–11].
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In spite of the fact that Lys49-PLA2 homologues are catalytically
inactive, they induce a strong myonecrotic effect that is inde-
pendent of phospholipid hydrolysis or arachidonic acid pathway
[12–14].  A number of models have been proposed to account for the
molecular basis of their pharmacological activities; however the
structural determinants remain elusive [10,11,14–21]. Lys49-PLA2
homologues have also been implicated in the inhibition of the vas-
cular endothelial growth factor [22] and exhibit broad antibacterial
activities [23,24], indicating their clinical and biomedical relevance.
Bothrops brazili snake is widely distributed in Brazil and its
venom contains two PLA2s [25]; myotoxin-I (MTX-I, Asp49) and
myotoxin-II (MTX-II, Lys49). MTX-II, which is enzymatically inac-
tive, induces strong myonecrosis and dose-time dependent edema
[26]. This toxin also display cytotoxic activity on human T-
cell leukemia (JURKAT) lines and microbicidal effects against
Escherichia coli, Candida albicans and Leishmania sp. [25]. In order
Open access under the Elsevier OA license. to shed light on the molecular basis for the biological effects of
MTX-II, its crystal structure was determined at 2.7 A˚ resolution pro-
viding details of the dimeric conﬁguration and the role of the Lys49
residue in the coordination of ligands, which suggests an important
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F razili.  (B) SDS-PAGE analysis of peaks from molecular size-exclusion chromatography. M:
m e 4; peak 4, Lane 5; peak 5, Lane 6; peak 6, Lane 7; peak 7. Lane 6 represents the puriﬁed
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0ig. 1. (A) Molecular size-exclusion chromatographic proﬁle of crude venom of B. b
olecular weight markers (kDa), Lane 1; peak 1, Lane 2; peak 2, Lane 3; peak 3, Lan
TX-II.
ontribution of the active site–like region in the expression of bio-
ogical activities.
. Materials and methods
.1. Puriﬁcation
Crude desiccated B. brazili venom was purchased from Ser-
entarium SANMARU Ltda, Taquaral, São Paulo, Brazil. 100 mg
f this sample was suspended in a 1.5 ml  solution (0.02 M Tris;
.15 M NaCl, pH 8.0) and centrifuged at 10,000 × g for 10 min.
he clear supernatant (1 ml)  was applied into a 16 cm × 60 cm
ephacryl S-100 column previously equilibrated with the same
uffer and eluted at a ﬂow rate of 0.2 ml  min−1 (Fig. 1A). All frac-
ions were analyzed by sodium dodecyl sulfate-polyacrylamide gel
lectrophoresis [27] (Fig. 1B).
.2. Dynamic light scattering
DLS measurements were performed on a Dynapro Molecular
izing instrument at 291 K. The samples were previously cen-
rifuged for 20 min  at 20,000 × g and then, illuminated with laser of
 m (diameter) and the intensity ﬂuctuations from the scattered
ight were measured in a 1 cm path length quartz cell. The data were
ollected with intervals of 10 s with at least 100 acquisitions. The
iffusion coefﬁcient (DT) was determined from the decay rate dis-
ribution of intensity correlation proﬁles and used to calculate the
ydrodynamic radius (Rh) of the protein via Stokes–Einstein equa-
ion (DT = kbT(6Rh)−1, where T is the temperature in Kelvin, kb is
he Boltzmann’s constant and  is the solvent viscosity). Analysis
as performed using the software Dynamics V6.3.40.
.3. Crystallization
The MTX-II sample was concentrated to 15 mg  ml−1 in micro-
oncentrators (AMICON) and crystallization was performed by
he hanging-drop vapor-diffusion method at 291 K using 24-well
issue-culture plates [28]. The sample was screened against com-
ercially available crystallization kits including crystal screen 1
nd 2, grid screen ammonium sulfate and grid screen polyethylene
lycol (PEG) 6000 (Hampton Research). Typically, 1 l of protein
olution was mixed with an equal volume of the screening solution
nd equilibrated over a reservoir containing 0.5 ml  of the crystal-
izing solution. Initial tests yielded micro-crystals in the condition
onsisting of 0.1 M Tris–HCl pH 8.5, 0.2 M MgCl2 and 18% (w/v) PEG
000. This condition was optimized and single crystals adequate
or X-ray diffraction were obtained when a 2 l protein droplet
as mixed with an equal volume of reservoir solution containing
.1 M Tris pH 8.2, 25% (w/v) PEG 4000 (Fig. 2).Fig. 2. Photomicrograph of MTX-II (maximum dimension: 200 m).
2.4. Data collection, processing and structure determination
A MTX-II crystal was  ﬂash-cooled in a 100 K nitrogen-gas stream
and X-ray diffraction data were collected on the W01B-MX2 beam-
line at the Brazilian Synchrotron Light Laboratory (LNLS-Campinas,
Brazil). The wavelength of the radiation source was  set to 1.458 A˚
and a MarMosaic 225 mm CCD detector was  used to record the
intensities. The crystal was  exposed for 90 s with a rotation of 2◦
per frame and a total of 90 images were collected using a sample-
to-detector distance of 100 mm.  The data were indexed, integrated
and scaled using the programs DENZO and SCALEPACK from the
HKL-2000 package [29]. Data-processing statistics are presented
in Table 1. Molecular replacement was carried out using the pro-
gram MOLREP [30] and a model based on the atomic coordinates
of bothropstoxin-I from Bothrops jararacussu (PDB ID: 2H8I [10]).
The structure factors and atomic coordinates were deposited in the
Protein Data Bank under the accession code 4DCF.
3. Results and discussion
3.1. Puriﬁcation
An efﬁcient and rapid procedure was established to purify the
MTX-II from B. brazili venom, which encompasses a single size-
exclusion chromatography on an S-100 Sephacryl column (Fig. 1A).
The protein was  obtained with purity higher than 95% (Fig. 1B)
and yielded 10 mg  of the protein from an initial amount of 100 mg
of crude venom. Under denaturing conditions, the puriﬁed MTX-
II migrated as a single protein band corresponding to a molecular
A. Ullah et al. / International Journal of Biologi
Table  1
Data collection and reﬁnement statistics.
Data collection
Temperature (K) 100
Radiation source Brazilian Synchrotron Light Laboratory
Beamline W01B-MX2
Wavelength (Å) 1.458
Detector MarMosaic 225 mm
Space group C121
Unit-cell parameters (Å,◦) a = 59.4, b = 128.88, c = 67.0;  ˛ =  = 90.0,
ˇ  = 105.66
Resolution range (Å) 19.72–2.70
Rmergea (%) 11.6 (33.9)
〈I/(I)〉 8.1 (2.6)
Data completeness (%) 94.2 (86.1)
Redundancy 3.0 (2.7)
Number of measured unique
reﬂections
12,516
Data analysis
VM (Å3 Da−1) 2.21
Solvent content (%) 44.26
Molecules per asymmetric unit 4
Model reﬁnement
Resolution range (Å) 19.72–2.70
Rfree (%) 31.98
Rfactor (%) 26.27
Number of reﬂections used in
reﬁnement
11,881
Number of protein atoms 3843
Water molecules 108
Ligands 2
R.m.s bond-length deviation (Å) 0.012
R.m.s bond-angle deviation (%) 1.472
Mean B-factor (Å2) 36.95
Ramachandran plot analysis
Most favored regions (%) 85
Allowed region (%) 15
Disallowed region (%) 0
a Rmerge =
∑ ∑
|Ii(hkl) − 〈I(hkl)〉|/
∑ ∑
Ii(hkl), where Ii(hkl) is the ith
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bservation of reﬂection hkl and 〈I(hkl)〉 is the weighted average intensity for all
bservations I of reﬂection hkl.
ass of 14 kDa, which is in a good agreement with the calculated
alue (13.7 kDa).
.2. Structural description
MTX-II was sequenced and characterized by 25 and 26,
espectively. The sequence comprises all the features of inac-
ive Lys49-PLA2 homologues including the residues Leu5, Gln11,
sn28, Leu32 and Lys49. Sequence alignment of MTX-II with
ther Bothrops Lys49-PLA2 homologues indicated that the puta-
ive catalytic apparatus (catalytic triad + Tyr73) is fully conserved
s well as the nominal calcium-binding loop. The most vari-
ble region is the C-terminus that may  have a key role in
yotoxicity [31–34].
The structure of MTX-II was solved at 2.7 A˚ resolution (Table 1)
y molecular replacement using the atomic coordinates of
othropstoxin-I from B. jararacussu (PDB ID: 2H8I [10]) as a tem-
late. The atomic model displayed good overall stereochemistry
ith RMSD values of 0.012 A˚ and 1.472◦ for bond lengths and
ngles, respectively. The average temperature factor (B-value) for
ll atoms is 36.95 A˚2 (Table 1) and 85.0% of the dihedral angles
re situated in the most favored regions, whereas the remain-
ng 15.0% of residues are found in either permitted or generously
llowed regions of the Ramachandran plot (Table 1). The asym-
etric unit consists of two dimers related by a two-fold axis ofotation.
The molecular topology of MTX-II conserves all the main
eatures of its homologues (Fig. 3A): the N-terminal -helix
1 (residues Ser1–Thr13); the short helical turn (residuescal Macromolecules 51 (2012) 209– 214 211
Pro17–Tyr21); the two  long anti-parallel disulﬁde-linked -helices
H2 (residues Ala39–Lys57) and H3 (residues Ser90–Glu108) that
are separated by 9 A˚; the -wing motif (residues Ser74–Gly86)
and the ﬂexible C-terminal region (Leu110-Cys133). The -
wing region is structurally conserved and is stabilized by two
salt bridges (Asp79A–Arg107B and Lys80A–Glu12B) between the
subunits forming the dimer of the asymmetric unit. Although
stabilized by two  disulﬁde bonds (Cys50-Cys133; Cys27-Cys127),
the C-terminal region of MTX-II displays high ﬂexibility as
observed by B-factors values (Fig. 3B) likely due to the
substitution of a conserved tyrosine by asparagine (residue
117) and the different conformational states observed for
Lys122.
3.3. Lys49 coordination and its role in the stabilization of
tetraethylene glycol
The active site-like region of Lys49-PLA2 homologues is formed
by His48, Lys49, Tyr52, Tyr73 and Asp99, and the catalytic water
molecule. The residues Gly28, Gly29, Arg32 and Gly33 are involved
in the coordination of Ca2+ ion in Asp49-PLA2s [35–38],  which plays
a role in the stabilization of the tetrahedral intermediate during
catalysis. In Lys49-PLA2 homologues, the Lys49-NZ atom is located
at the position of the Ca2+ ion and is coordinated by the backbone
atoms from the CGVG/LGR motif.
In the MTX-II structure, the two  dimers forming the asymmet-
ric unit display different conformational states due to the presence
of tetraethylene glycol (TTEG) bound to the dimer formed by
molecules A and B. In the case of the second dimer formed by
molecules C and D where the active site-like region is empty, the
Lys49 side-chain is mono-coordinated by the carbonyl oxygen atom
of Val31 (Fig. 4A). In molecule B, a TTEG molecule is found at
the active site-like region and it is stabilized by a single hydro-
gen bond formed between its terminal hydroxyl group and Gly30
(Fig. 4B). In molecule A, TTEG is anchored to the nominal calcium-
binding loop by the backbone of Gly30 analogously to molecule
B and additionally by the NZ atom of Lys49, suggesting a con-
tribution of Lys49 in the functioning of Lys49-PLA2 homologues
(Fig. 4C). In BthTX-I structure, a PEG fragment was also encountered
bound to the active site-like region, conserving the hydrogen bond
with Gly30 and making water-mediated interactions with His48
[10]. Fatty acids [39,40] and stearic acid [41] were also observed at
the active site-like region of other Lys49-PLA2 homologues, which
supports the importance of this interface for the expression of
their pharmacological activities including myonecrosis and edema
formation.
A correlation between the presence of the ligand at the active
site-like region and the coordination of Lys49 was observed in the
MTX-II structure. When Lys49 participates in the stabilization of
TTEG, the carbonyl oxygens of Asn28 and Val31 are coordinated by
the Lys49 side-chain, whereas in the unbound state Lys49 coor-
dination is done by the carbonyl oxygens of Val31 and Gly33.
These conformational changes in the nominal calcium-binding loop
reﬂect in a rearrangement of the C-terminal region, which modiﬁes
the polarization and surface hydrophobicity.
The observed coordination modes of the Lys49 residue contrast
with those already described for other Lys49-PLA2 homologues,
wherein the NZ atom is generally tri-coordinated by the backbone
of atoms of residues Asn28, Gly30 and Gly33 [20]. In the Arg49-
PLA2 homologue, the substitution of Lys49 by Arg results in thebonyl oxygens and mono-coordination of the Arg49NH2 atom by
the backbone of the residue Gly30, still preserving the triple coor-
dination by the canonical residues.
212 A. Ullah et al. / International Journal of Biological Macromolecules 51 (2012) 209– 214
Fig. 3. (A) Overall structure of MTX-II. N-terminal -helix H1 (residues Ser1–Thr13); one short helical turn (residues Pro17–Tyr21); the two long anti-parallel disulﬁde-linked
 ted by
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r-helices H2 (residues Asp39-Lys57) and H3 (residues Ser90-E108) that are separa
Leu110-Cys133). Nominal calcium binding loop are in blue. (B) MTX-II ﬂexibility. R
his  ﬁgure legend, the reader is referred to the web  version of this article.)
.4. Unpolarized state of the C-terminal region in the presence of
igands
Different mechanisms have been proposed to the myonecrotic
ctivity of Lys49-PLA2 homologues related to their dimeric confor-
ation [6,10,42] and formation of the hydrophobic knuckle [40].
n the latter model, the hyperpolarization of the peptide bond
etween residues Cys29 and Gly30 due to the presence of Lys122
auses a local rearrangement of the C-terminal residues (Fig. 4D).
ig. 4. (A) Relaxed conformational state of molecules C and D of MTX-II, where the Lys49
,  the tetraethylene glycol (green) is only stabilized by Gly30 amide bond. (C) The molecu
inding loop by the backbone of Gly30 and by the Lys49NZ atom. (D) Comparison of the u
ith  the hyperpolarized state of the Lys49-PLA2 homologue from Agkistrodon contortrix
etween  residues Cys29 and Gly30 (carbon atoms in green). In MTX-II structure, Lys122 
eferences to color in this ﬁgure legend, the reader is referred to the web version of this a 9 A˚; the -wing region (residues Ser74–Gly85) and the ﬂexible C-terminal region
 representation colored by B-factor. (For interpretation of the references to color in
This is then locked into a conformation with the hydrophobic
residues, Phe121 and Phe124 forming a hydrophobic knuckle that
is exposed to the solvent and is considered essential for interaction
with the membrane (Fig. 4D). However, in the MTX-II structure,
the presence of tetraethylene glycol interacting with the nominal
calcium-binding loop and Lys49 does not result in the formation
of the hydrophobic knuckle. Analogously to MTX-II, the Zhaoer-
miatoxin (Arg49-PLA2) in complex with a ligand also exhibits a
C-terminal conformation where the hydrophobic residues are not
 side-chain is mono-coordinated by carbonyl oxygen of Val31. (B) In the molecule
le A of MTX-II with tetraethylene glycol (green) anchored to the nominal calcium-
npolarized state of the C-terminal region in the presence of ligands (MTX-II, blue)
 (green). The presence of Lys122 in the active site hyperpolarizes the amide bond
displays a different conformation (carbon atoms in blue). (For interpretation of the
rticle.)
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xposed to the solvent. These results show that Lys49-PLA2 homo-
ogues undergo structural rearrangements in the C-terminus when
he active site-like region is occupied, providing new insights into
heir molecular mechanisms.
.5. Oligomerization
All Lys49-PLA2 homologues are characterized as dimers in
olution and two dimeric conﬁgurations have been proposed for
ys49-PLA2 homologues; an extended and a compact conforma-
ion [10,18,43] (Fig. 5). In the extended dimer, formed by hydrogen
onds between the -wings, the hydrophobic channel and active-
ite cleft are exposed to the solvent [18,43], forming a common,
arge hydrophobic surface enabling the interaction with mem-
ranes. In the compact dimer, non-polar contacts predominate
nd the hydrophobic surface surrounding the PLA2-active site-like
egions are shielded from the solvent [10,20]. To date, all Lys49-
LA2 homologue structures available in the Protein Data Bank can
e interchangeably assembled in the two possible conﬁgurations.
AXS studies and crystal structure of several ligand complexes have
een indicating the compact dimer as the biological assembly for
ys49-PLA2 homologues.
DLS experiments also conﬁrmed the dimeric state of MTX-
I (results not shown) and crystal packing analysis showed that
nly the extended dimer can be formed using all possible sym-
etry operations. This is the unique crystal structure in which the
ompact dimer cannot be assembled by symmetry operations, sug-
esting that structural rearrangements by the presence of ligand
ould induce a switch between these two possible conformations
r simply indicates that the extended dimer is the more likely bio-
ogical unit of Lys49-PLA2 homologues.
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